BIOMARIN PHARMACEUTICAL INC Asset Retirement Obligation, Accretion Expense
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Asset Retirement Obligation, Accretion Expense of $107.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetRetirementObligationAccretionExpense · last filed 2017-02-27
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for the quarter ending 2016-12-31 was $28.00K, a 28.21% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for the quarter ending 2016-09-30 was $39.00K, a 2.50% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for the quarter ending 2016-06-30 was $38.00K, a 15.15% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for the quarter ending 2016-03-31 was $2.00K, a 94.44% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for fiscal 2016 was $107.00K, a 27.70% decline from fiscal 2015.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for fiscal 2015 was $148.00K, a 18.68% decline from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for fiscal 2014 was $182.00K, a 17.42% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, accretion expense for fiscal 2013 was $155.00K.
| Period end | Asset Retirement Obligation, Accretion Expense 3 month | Asset Retirement Obligation, Accretion Expense 6 month | Asset Retirement Obligation, Accretion Expense 9 month | Asset Retirement Obligation, Accretion Expense 12 month |
|---|---|---|---|---|
| 2016-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $67.00K derived: sum of 2 quarters · filed 2017-02-27 | $105.00K derived: sum of 3 quarters · filed 2017-02-27 | $107.00K 10-K · filed 2017-02-27 |
| 2016-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $77.00K derived: sum of 2 quarters · filed 2016-11-03 | $79.00K 10-Q · filed 2016-11-03 | $118.00K derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $40.00K 10-Q · filed 2016-08-08 | $79.00K derived: sum of 3 quarters · filed 2016-08-08 | $119.00K derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | $2.00K 10-Q · filed 2016-05-02 | $41.00K derived: sum of 2 quarters · filed 2016-05-02 | $81.00K derived: sum of 3 quarters · filed 2016-05-02 | $114.00K derived: sum of 4 quarters · filed 2016-05-02 |
| 2015-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $79.00K derived: sum of 2 quarters · filed 2016-02-29 | $112.00K derived: sum of 3 quarters · filed 2016-02-29 | $148.00K 10-K · filed 2016-02-29 |
| 2015-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $73.00K derived: sum of 2 quarters · filed 2015-11-02 | $109.00K 10-Q · filed 2015-11-02 | $205.00K derived: sum of 4 quarters · filed 2015-11-02 |
| 2015-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $69.00K 10-Q · filed 2015-08-05 | $165.00K derived: sum of 3 quarters · filed 2015-08-05 | $191.00K derived: sum of 4 quarters · filed 2015-08-05 |
| 2015-03-31 | $36.00K 10-Q · filed 2015-05-05 | $132.00K derived: sum of 2 quarters · filed 2015-05-05 | $158.00K derived: sum of 3 quarters · filed 2015-05-05 | $188.00K derived: sum of 4 quarters · filed 2015-05-05 |
| 2014-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $122.00K derived: sum of 2 quarters · filed 2015-03-02 | $152.00K derived: sum of 3 quarters · filed 2015-03-02 | $182.00K 10-K · filed 2015-03-02 |
| 2014-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $56.00K derived: sum of 2 quarters · filed 2014-10-28 | $86.00K 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $60.00K 10-Q · filed 2014-07-31 | ||
| 2014-03-31 | $30.00K 10-Q · filed 2014-05-02 | |||
| 2013-12-31 | $155.00K 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |